Endocrinology

1-11 of 11

CME/CE In-Person & Virtual Event
Beyond the Scale: Assessing the Quality of Weight Loss and Advancing a Whole-Person Approach to Obesity Care
15 november, 2026
Oxon Hill, Maryland
1.25 credits
Finerenone in Patients With FSGS: A FIND-CKD Analysis
Finerenone in Patients With FSGS: A FIND-CKD Analysis
Kidney Disease
Finerenone in Patients With FSGS: A FIND-CKD Analysis
prof. Hiddo Heerspink
- prof. Hiddo Heerspink
Finerenone and SGLT2 Inhibitors in Non-Diabetic CKD: Insights From FIND-CKD
Finerenone and SGLT2 Inhibitors in Non-Diabetic CKD: Insights From FIND-CKD
Kidney Disease
Finerenone and SGLT2 Inhibitors in Non-Diabetic CKD: Insights From FIND-CKD
David Cherney, MD, PhD
- David Cherney, MD, PhD
EASD 2026: Changing the Set Point—A New Era in Obesity Management on the Horizon
EASD 2026: Changing the Set Point—A New Era in Obesity Management on the Horizon
Obesity
EASD 2026: Changing the Set Point—A New Era in Obesity Management on the Horizon
Carel le Roux, MBChB, MSC, FRCP, FRCPath, PhD
- Carel le Roux, MBChB, MSC, FRCP, FRCPath, PhD
Changing the Trajectory: Why Earlier Obesity Treatment Matters
Changing the Trajectory: Why Earlier Obesity Treatment Matters
Obesity
Changing the Trajectory: Why Earlier Obesity Treatment Matters
Elisabeth Van Rossum, MD, PhD; William Mencia, MD, FACEHP
- Elisabeth Van Rossum, MD, PhD
- William Mencia, MD, FACEHP
EASD 2026: The Importance of Protecting Lean Muscle Mass in Managing Patients With Obesity
EASD 2026: The Importance of Protecting Lean Muscle Mass in Managing Patients With Obesity
Obesity
EASD 2026: The Importance of Protecting Lean Muscle Mass in Managing Patients With Obesity
Stefan D. Anker, MD, PhD
- Stefan D. Anker, MD, PhD
EASD 2026: The Evolving PCP Role in Managing Patients With CKM Diseases
EASD 2026: The Evolving PCP Role in Managing Patients With CKM Diseases
Kidney Disease
EASD 2026: The Evolving PCP Role in Managing Patients With CKM Diseases
Ana Maria Cebrián-Cuenca, MD, PhD
- Ana Maria Cebrián-Cuenca, MD, PhD
Amylin Therapies: What's on the Horizon for Obesity and Metabolic Care?
Amylin Therapies: What's on the Horizon for Obesity and Metabolic Care?
Obesity
Amylin Therapies: What's on the Horizon for Obesity and Metabolic Care?
W. Timothy Garvey, MD, MACE, FTOS
- W. Timothy Garvey, MD, MACE, FTOS
Connecting the Dots in Obesity Care: Key Takeaways From EASD 2026
Connecting the Dots in Obesity Care: Key Takeaways From EASD 2026
Obesity
Connecting the Dots in Obesity Care: Key Takeaways From EASD 2026
Elisabeth Van Rossum, MD, PhD; William Mencia, MD, FACEHP
- Elisabeth Van Rossum, MD, PhD
- William Mencia, MD, FACEHP
TRIUMPH-2: Translating New Obesity Data Into Real-World Care
TRIUMPH-2: Translating New Obesity Data Into Real-World Care
Obesity
TRIUMPH-2: Translating New Obesity Data Into Real-World Care
Elisabeth Van Rossum, MD, PhD; William Mencia, MD, FACEHP
- Elisabeth Van Rossum, MD, PhD
- William Mencia, MD, FACEHP
Looking Beyond the Scale: Identifying the Drivers of Obesity
Looking Beyond the Scale: Identifying the Drivers of Obesity
Endocrinology
Looking Beyond the Scale: Identifying the Drivers of Obesity
Elisabeth Van Rossum, MD, PhD; William Mencia, MD, FACEHP
- Elisabeth Van Rossum, MD, PhD
- William Mencia, MD, FACEHP

1-11 of 11

Title